chrisvoncsefalvay/vaers-outcomes huggingface dataset:
New joint swelling in the knees and fingers, strange muscular swelling/lumps after muscle stimulation.  Ie got a pedicure a week after the 2nd vaccine, everywhere the massage chair touched resulted in large swollen lumps. For months following I had swollen knees or hot, itchy lumps in knee muscles with no pattern/cause. Went for blood work after my fingers became continuously swollen, stiff and painful in august.  Also experienced extreme vertigo and morning dizziness from the months of July through November.
Lightheadedness and pounding heart about 8 minutes after receiving second dose.  The pounding heart went away about an hour after receiving vaccine.  This did not feel like a panic attack.  Nothing I did (slow breathing, drinking water, sitting on the couch) would help.  But then after about an hour it just stopped.  Still having lightheadedness, nausea and diarrhea on May 10th.  The lightheadedness sometimes goes away but keeps coming back.  I can't drive or walk very far because of it.   Also very hard to concentrate.  Found many other people having the same symptoms after the vaccines.
Pt was administered the BOOSTRIX vaccine on 4/1/13. Pt returned to office 4/6/13 c/o lymphadenopathy in the arm.
Child developed nystagmus 2 hours post vaccination. Patient developed gastrointestinal distress including constipation from 5 hours post vaccination until 5 days post vaccination. Child also developed eczema
Pain in my left arm, between the shoulder and elbow, in the muscle of the injection site. Pain at the injection site when pressed. Limited motion of my arm. I experience pain when I: bend my arm back towards my back, as if to scratch my back; try to lift something with my left arm; try to remove my shirt; raise my arm above my head; reach my left arm across my body to wash my right shoulder - I can't reach past my shoulder to my back, nor can I apply pressure to wash. Pain seems to lessen when I take 2 ibuprofen tablets. I still have pain everyday.
Feels dizzy, nauseous, stomach cramps, low grade fever and chills Treatment: increase fluid intake to keep hydrated. TYLENOL for fever, see doctor if symptoms worsen.
Only the diluent portion was given; Only the diluent portion was given; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 51-year-old female patient who received Herpes zoster (Shingrix) (batch number AP545, expiry date 25th January 2023) for prophylaxis.   On 9th April 2021, the patient received the 1st dose of Shingrix. On 9th April 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The patient received only the diluent portion of the Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter reported that, the diluent was not reconstituted with the powder and only the adjuvant was given. The reporter confirmed the correct batch number of Shingrix. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021216670:Same reporter. US-GLAXOSMITHKLINE-US2021216677:Same reporter.
CoughWheeze, Diarrhea, NauseaVomiting, BACK PAIN Narrative:
34 YO received Shingrix; was given Shingrix instead of varicella; This case was reported by a pharmacist via sales rep and described the occurrence of inappropriate age at vaccine administration in a 34-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   Additional Information: GSK Receipt Date: 10-FEB-2023 Reporter's Comment:  The reporter reported that the 34 years old patient received Shingrix vaccine instead of varicella vaccine. No adverse event. Additional supportive information: The patient received Shingrix who was younger than the indicated age which led to inappropriate age at vaccine administration. The reporter reported that, they were intending to administered varicella and inadvertently administered Shingrix instead of varicella, which led to wrong vaccine administered.
Received vaccine 2/2/05-seen by MD on 2/3/05 in which L leg swollen 2 inches more than R slightly pinkish. Indurated all throughout entire middle third of thigh. Limping some is able to walk. Full ROM mild to moderately tender.
The day of the vax I had typical side effects like fever, body aches, chills for about 2 days.  After that, it felt like I had a rash and my entire body felt inflamed but there was no visible rash which lasted for about 3 weeks.  I experienced a lot of joint and muscle pain.  Pain in my knees and swelling in my ankles.  I called my dr and they recommended I take Benadryl and Tylenol and my symptoms slowly dissipated.
First time getting flu injection. 8:55 am c/o feeling funny, cold & clammy, vomited small amount BP 142/98 P 96 R 18. Stated is borderline hypertensive. 9:10 AM Bp 112/68 p 74 R 18 discharged.
The patient had COVID last March; The patient had COVID last March; Chills; Malaise; Night sweats; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), administration date 17Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), with onset of Mar2021, outcome "unknown" and all described as "The patient had COVID last March"; CHILLS (non-serious) with onset 17Feb2021, outcome "unknown", described as "Chills"; MALAISE (non-serious) with onset 17Feb2021, outcome "unknown", described as "Malaise"; NIGHT SWEATS (non-serious) with onset 17Feb2021, outcome "unknown", described as "Night sweats". The patient underwent the following laboratory tests and procedures: sars-cov-2 antibody test: (unspecified date) positive, notes: May; sars-cov-2 test: (Mar2021) positive. She just has a question. She was glad she got the Pfizer shot instead of other brands. Last March she had COVID. She tested positive for antibodies in May. She didn't have shortness of breath, but she had other symptoms. She got the first shot 17Feb2021. She got chills, malaise, and night sweats. The night sweats were like when you are getting over COVID, but not as bad as when she had COVID.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Chills and fever (~101.0F) at initial onset which lasted approximately 8 hours.  Fatigue which lasted ~24 hours.  Nausea which lasted ~8 hours.  All resolved 48 hours after injection.
no adverse event; 9 month old patient was administered VAQTA; This spontaneous report was received from a physician via company representative, referring to a 9-month-old patient of unknown gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.      On 18-FEB-2021, a 9-month-old patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) for prophylaxis (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) (product administered to patient of inappropriate age). No additional adverse event reported.
Headache, nausea, dizziness, feeling faint. Checked with Pharmacists and rested in bed for one day with lots of fluids and light food.
Immediately after being vaccinated the patient requested to lie on the floor because she felt dizzy. RN place patient in a reclining position and requested evaluation of patient by NP.Patient was pale, and diaphoretic.Patient denied chest pain, SOB, N/V, negative rash, negative facial swelling,Pt was Hypotensive.EMS was activated .Repeat V/S 3 minutes later were WNL pt remained A&O throughout encounter.Pt stated " this has happened before". Patient was transported to Hospital Via EMS
Dizzy- for two days Vomiting - twice the afternoon I received the vaccine Chills- around 2am for 4 hours  Weakness- severe weakness the following morning  Blacked out the morning after
Temp 101.9 and 102.6; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the arm left on 21Apr2021 at 09:15 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included Factor V Leiden carrier. It was unknown whether the patient was pregnant at the time of vaccination. Concomitant medications included paracetamol (TYLENOL) and cetirizine hydrochloride (ZYRTEC) for unknown indication from an unknown date. It was unknown whether the patient was allergic to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 21Apr2021, at 10:00 the patient had temperature of  101.9 (Unspecified units) and 102.6 (Unspecified units). The event resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the event and included treatment with diphenhydramine hydrochloride (BENADRYL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Temp 101.9 and 102.6 was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.
Nausea; Vomiting and not able to retain anything; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Vomiting and not able to retain anything) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Oct-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 11-Oct-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting and not able to retain anything). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency and FRUCTOSE, GLUCOSE, PHOSPHORIC ACID (EMETROL [FRUCTOSE;GLUCOSE;PHOSPHORIC ACID]) for Nausea, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Vomiting and not able to retain anything) outcome was unknown.            No concomitant medications were provided.
5 cm x 3 cm induration, with surrounding skin 7 cm of erythema and warmth, body aches with temp as high as 102.3 over the last 2 days.
CHILLS STARTING 1 OR 2 WEEKS AFTER 1ST SHOT AND CONTINUING
i have a burning when my cloths touch my skin; some pain; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of burning sensation skin in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. In JUN-2023, an unknown time after receiving Shingles vaccine, the patient experienced burning sensation skin (Verbatim: i have a burning when my cloths touch my skin) and pain (Verbatim: some pain). The outcome of the burning sensation skin and pain were not resolved.   It was unknown if the reporter considered the burning sensation skin and pain to be related to Shingles vaccine.     It was unknown if the company considered the burning sensation skin and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 20-JUN-2023 The patient self-reported this case. This case was reported by a patient via interactive digital media. The patient got the two shots this might the last one but for the last 4 days on back around bra and had a burning when cloths touched the skin and some pain when moved a certain way. The reporter asked if anyone could still get shingles after the shots or was this something else.
Sore and slightly swollen arm and  the day of and for the next week.   Received Covid injection on Dec. 28, 2021.  On January 2, 2022 dry cough,  no fever, sore throat,  runny nose.  Several days later red eyelids and watery eyes.  Continued for 3 weeks.  Unable to see doctor.  Received 2nd Shingrix vaccine on March 1st.  Sore and slightly swollen arm.  Mild headache that Naproxen relieved.  On March  3,  runny nose and dry cough, no fever.  March 4th  yellow nasal discharge.   Recovered from 1st vaccine but still experiencing effects from 2nd vaccine.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Mar2021 as dose 1, single (Lot number: ER8730), in left arm, on 21Apr2021 as dose 2, single (Lot number: EW0170), in left arm and on 24Oct2021 as dose 3 (booster), single (Lot number: 3203080) at the age of 56 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ZOLOFT. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of vaccination failure, covid-19 included Tab Paxlovid.  Clinical course: Other medication in 2weeks yes. Reported in split case, became ill again 5 days after completion of Paxlovid. Terrible acidic, bitter taste in mouth, diarrhea, general feeling of malaise .She had no known allergies and no relevant medical history. Covid-19 treatment was done with Paxlovid from 09Jul2022 to 15Jul2022.
Administration of an expired Bexsero dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-year-old male patient who received Men B NVS (Bexsero) (batch number ABXC08AA, expiry date 31-MAR-2023) for prophylaxis.  On 07-APR-2023, the patient received Bexsero. On 07-APR-2023, an unknown time after receiving Bexsero, the patient experienced expired vaccine used (Verbatim: Administration of an expired Bexsero dose). The outcome of the expired vaccine used was unknown.  This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional Information: GSK Receipt Date: 07-APR-2023 A nurse had called in to report the administration of an expired Bexsero dose patient.  The Healthcare Professional (HCP) had asked if they had to repeat the dose. The reporter had consented to follow-up.  At the time of reporting, the patient received a dose of expired Bexsero vaccine, which had led to expired vaccine used.
One day post vax, the pt experienced an itching face and ears, swelling ear and urticaria on neck.  Outpatient treatment was required, and the pt was treated with prednisone and Chlortrimeton. The most recent information received reports the outcome of the event as unknown.
FEVER, CHILLS, NAUSEA, SWEATS, CHILLS, RED SWOLLEN ARM, SORENESS, KNOT AT THE SITE, CELLULITIS SET IN.
For 2 days I had fatigue and lethargic but tested negative for COVID-19. The 3rd day I tested positive for COVID-19 I had headache; coughing; tired and a fever. I called my doctor and they prescribed me PAXLOVID. My symptoms lasted for 25 days and tested positive for 23 days. Still have lingering cough and fatigue but mostly better.
After one week, itchy red rash about 4" across at injection site. Not excoriated or weeping. Easily controlled with topical hydrocortisone. Lasted about a week. I was virtually raised in a barn. For more than a decade, I frequently inhaled the dust of dried manure from numerous bird, bat, and quadruped species. Consequently, my immune system has always been ready for war; I have rarely missed a day of work in my long professional career. I suspect my "COVID arm" represents my normal battle-ready immune system at work.
sore back; This is a spontaneous report from a Pfizer-sponsored program, received from a contactable consumer (patient). A male patient of an unspecified age (age: 65, unit: unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient took 2 Tylenols about 8 hours prior to second dose of the Pfizer vaccine due to sore back from shoveling on an unspecified date. The Tylenol was not related to the first dose. Outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old male patient received BNT162b2 (BNT162B2), on 29Nov2021 as dose 3 (booster), single (Lot number: FJ1620) at the age of 46 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing); "Hypertension" (unspecified if ongoing). The patient had no known allergy. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Aug2022) positive. Clinical course: The patient had rebound of COVID with symptoms and positive antigen test approximately 6 days after finishing 5 day paxlovid (08Aug2022). Paxlovid was given from 28Jul2022 to 02Aug2022 as COVID 19 treatment.  No follow-up attempts are possible. No further information is expected.
couldn't get the second dose due to the GSK shortage.; light fever; swollen left arm; This case was reported by a consumer via call center representative and described the occurrence of fever in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in June 2018).   In August 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, between 5 and 7 months after receiving Shingrix, the patient experienced fever, swelling arm and product supply issue. On an unknown date, the outcome of the fever and swelling arm were recovered/resolved and the outcome of the product supply issue was unknown.   It was unknown if the reporter considered the fever and swelling arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The patient couldn't get the second dose due to the GSK shortage.  The patient had a well visit at her physician's office and they referred her to an independent pharmacy who had the vaccine in stock.   The pharmacist informed her that because she missed the 2 to 6 month window for the second dose, she would need to restart the vaccine series.   She received both shots in her left arm intramuscularly.  The patient also reported a light fever and swollen left arm for three days after the vaccinations and the swelling resolved with ice. The reporter consented to follow up.
Headache, muscle pain, tired, slight fever Lasted about 48 hours Took Acetaminophen
Patient vaccinated 1st dose to Left deltoid @13:14. 1322 noted by staff RN using inhaler. with c/o of difficulty breathing, and a little chest pressure. BP 13:23 136/85 94 99% RA and noted as appearing to be somewhat anxious and is tearful. Patient voiced concern regarding getting medical attention, "my husband. my husband does not know." 13:27 recheck BP 105/65 93 and 99% RA no changes in symptoms. Patient somewhat guarded with questions and assessment. 13:34 105/63 93 100% RA noted coloring good however, with c/o some slight  throat tightness. Team Lead informed patient plan is to have patient be evaluated at ER, transport via EMS. Mall security informed and EMS called. 13:40 103/58 93 and 100 % RA patient A&O x3. tearful and appears very concerned about husband voicing, "I can't, my husband doesn't know." 1341: HFD onsite, BP 112/82 102 and 98% RA.  14:24: EMS; paramedic returns to clinic to inform Team Lead, that patient is refusing transport and evaluation at ED. Paramedic and Team Lead tried to encourage patient to accept help. Patient appears to be afraid. Patient refused and EMS left. 14:45 noted by staff patient is still in the front of clinic. Team Lead checked on patient. Patient states she is feeling better and thanks staff. However is still hanging around clinic and appears to have the look of uncertainty.
swelling around right elbow; redness around right elbow; warmth around right elbow; This spontaneous report has been received from a medical assistant and refers to a 66-year-old female patient. There was no information regarding the patient's medical history, concurrent conditions and concomitant medications provided.  On 06-FEB-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) injection, intramuscularly, lot # W019533 confirmed to be valid with expiration date 30-SEP-2023 (exact dose, dose number and anatomical location were not reported), for prevention of pneumococcal disease (prophylaxis).  On the same date, the patient experienced redness, warmth, and swelling around right elbow, which was present since the administration of the suspect vaccine. On that day, the patient went to urgent care and was treated with loratadine (CLARITIN) and diphenhydramine (BENADRYL). The patient was instructed by a healthcare professional at the reporter's facility to continue loratadine (CLARITIN) in the morning and diphenhydramine (BENADRYL) in the evening. At the reporting time, the patient was recovering from the events.  The causality assessment between the events and the suspect vaccine was not provided.  This is one of 2 reports from the same reporter.
Had a significant rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Had a significant rash) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0UM28) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced RASH (Had a significant rash). At the time of the report, RASH (Had a significant rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    No treatment information was reported.   Reporter did not allow further contact
Starting after one week, injection site is swollen, itchy, red, slightly painful, rash